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Background. Large-scale poisonings caused bymethyl mercury (MeHg) have occurred in Japan (Minamata in the 1950s andNiigata
in the 1960s) and Iraq (in the 1970s). The current WHO neurological risk standard for adult exposure (hair level: 50 µg/g) was
based partly on evidence from Niigata which did not consider any cases who were diagnosed later and/or exposed to low level of
MeHg (hair mercury level less than 50 µg/g). Methods. Early in the Niigata epidemic in June 1965 there were two extensive surveys.
From these two surveys, we examined 103 adults with hair mercury measurement who consulted two medical institutions. We
compared the prevalence and the distribution of neurological signs related toMeHg poisoning between exposure categories. Result.
We found 48 subjects with neurological signs related to MeHg poisoning who had hair mercury concentration less than 50 µg/g.
Among the neurological signs, sensory disturbance of the bilateral distal extremities was observed more frequently, followed by
disequilibrium, hearing impairment, and ataxia, in groups with hair MeHg concentration both below 50 µg/g and over 50 µg/g.
Conclusion. The present study suggests the possibility that exposure to MeHg at levels below the current WHO limits could cause
neurologic signs, in particular, sensory disturbance.
1. Introduction
Large-scale poisonings caused by methyl mercury (MeHg)
have occurred in Japan (Minamata in the 1950s and Niigata
in the 1960s) and Iraq (in the 1970s) [1–3]. These poisonings
provided substantial data regarding the neurologic signs
caused by MeHg: sensory disturbance, ataxia, constriction of
the visual field, speech disturbance, and hearing impairment
[1–7]. In Minamata, the etiologic agent (MeHg) was not
acknowledged until three years after oﬃcial identification
of the exposed cases (in 1956); thus, there were few
attempts to evaluate the association betweenMeHg exposure
and neurologic signs (i.e., dose-response relationships).
In contrast, in the settings of Niigata and Iraq, MeHg
was recognized as an etiologic agent in the early phase
of the poisonings [1, 5, 7], which provided the occasions
to examine the dose-response relationships. The findings
from these two poisonings therefore provided significant
insights for World Health Organization (WHO) conclusion
on mercury and health [1, 8].
Indeed, WHO published two reports of Environmental
Health Criteria in 1976 and 1990 based on the findings from
the Japanese and Iraqi outbreaks [1, 8–10]. Then, WHO
concluded that “Certain groups with high fish consumption
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may attain a high blood methyl mercury level (about
200 µg/liter, corresponding to 50 µg/g of hair) associated
with a low (5%) risk of neurological damage to adults” [9].
The reports also mentioned that “No adverse eﬀects have
been detected with long-term daily methyl mercury intakes
of 3–7 µg/kg body weight (hair mercury concentrations of
approximately 50–125 µg/g)” [9]. In the process of mak-
ing the conclusion, WHO reports cited publications from
Niigata which mentioned that the mercury content in hair
samples from 30 initial patients, oﬃcially certified as having
MeHg poisoning, ranged from 52 µg/g to 570 µg/g [3, 11, 12].
However, the publications did not consider any cases who
were diagnosed later and/or exposed low level of MeHg
(hair mercury level less than 50 µg/g), possibly distorting the
conclusion of WHO.
Early on in the Niigata poisoning in 1965, there were
two extensive surveys of people living along the Agano River
and the adjacent areas, which included assessment of hair
mercury concentration. In the present study, we targeted 103
adults from the surveys and examined whether neurological
signs related to MeHg exposure were observed below hair
mercury concentration of 50 µg/g as well as the distributions
of the neurological signs among the participants. Because
MeHg exposure through fish consumption has attracted
intense public health interest [13], the findings from Niigata
would be valuable.
2. Material and Methods
2.1. Study Areas and Subjects. In Niigata Japan, the first case
of MeHg poisoning was found in January, the second in
April, and the third in May, of 1965. Seven patients were
confirmed before June and all lived around the lower stream
of the Agano River. Their exposure was due to consumption
of fish and shellfish contaminated by MeHg discharged from
a chemical factory (ShowaDenko Kanose Factory) located on
the upper reaches of the Agano River [3, 5, 6, 11, 12, 14]. The
total mercury content of fish samples collected in June 1965
from the Agano River was elevated (barbel, 21.0∼23.6 ppm;
snakehead mullet, 12.3 ppm; chub, 4.6∼8.38 ppm) and one
eel captured near Tsugawa town (a town along the Agano
River) had 41.0 ppm [7].
In June 1965, two surveys were carried out for all oﬃcially
registered inhabitants of five administrative districts located
within 15 km from the mouth of the river where the seven
patients lived. The administrative districts were composed of
the parts of 2 cities, 2 towns, and one village, consisting of 65
settlements. The first survey was conducted in 6 settlements
where the first 7 patients lived between June 14, 1965 and
June 18, 1965 by medical doctors, interns, and students from
the Niigata University Medical Department. The second
survey was performed between June 21, 1965 and June 24,
1965 by the Niigata Prefecture Sanitation Department in the
remaining 59 settlements of the districts. The second survey
included public health nurses from the prefectural health
centers as well [5, 7, 15].
The sampling process of the study subjects from these
two surveys is shown in Figure 1. In the first survey, 2,813
inhabitants were interviewed using a standardized question-
naire to determine the extent of their MeHg exposure. The
survey focused on symptoms related to MeHg exposure and
river fish consumption. Subjects with symptoms suggestive
of MeHg exposure were subsequently examined neurologi-
cally. The second survey was done in the same fashion on
19,888 inhabitants of the lower reaches of the Agano River
basin.
From these interviews, 1,386 persons were identified
as being exposed because they had symptoms or findings
suggestive of MeHg exposure; because other family members
had symptoms related to MeHg poisoning; or because they
consumed river fish in large quantities. Subsequently, their
total hair mercury concentration was measured [5, 7]. After
that, in July 1965, Niigata Prefecture restricted the taking of
fish and shellfish on the lower reaches of the Agano River.
Among 1,386 persons, 109 subjects who had symptoms
related to MeHg poisoning as chief complaints voluntarily
consulted at either (or both) of two medical institutions
(Nuttari clinic and Kido hospital) for medical care for the
first time during the period of 1965 to 1986. The two insti-
tutions are medical institutions which have followed MeHg
poisoning cases in Niigata just after the outbreak in 1965,
cooperating with Niigata University. Most of the patients still
consult at either (or both) of the two medical institutions
for medical care. In the present study, we included 103
adults (20 years old) and considered the neurological
manifestations observed at their first consultation.
2.2. Measurement of MeHg in Hair. The subjects had their
hair collected before the restriction of fish and shellfish
(in July 1965) and were believed to be consuming the
contaminated fish and shellfish when mercury was mea-
sured. The mercury content of hair samples was measured
using 3 diﬀerent techniques: the Dithizone method, Neutron
Activation Analysis, and Atomic Absorption Spectroscopy at
the Niigata University [5, 7]. We report the values without
any interpolation.
2.3. Measurement of Outcomes (Diagnosis of Neurological
Signs from MeHg Exposure). The 103 subjects were evaluated
using a standard neurological examination by at least two
well-trained physicians including two of the authors in the
present study (T. Sekikawa and H. Saito) between 1965 and
1986. In particular, one of the authors (H. Saito) has been
treating the MeHg poisoning cases since the outbreak in
1965 at the two medical institutions up to the present and
was involved in all of the neurological examinations. Thus,
neurological examination was standardized over the study
period and between the examiners. Data were collected on
neurological signs related to MeHg poisoning, namely, sen-
sory disturbance of the distal extremities, perioral area, and
whole body; ataxia; visual constriction; hearing impairment;
speech disturbance; disequilibrium. However, not all subjects
underwent all neurological tests: data on whole body sensory
disturbance, visual constriction, hearing impairment, speech
disturbance, and disequilibrium were missing for 7, 8, 9,
7, 1 study subjects, respectively. In the previous study in
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Positive screening if one of the following: 
had symptoms or findings suggestive of MeHg exposure; 
consumed river fish in large quantities;  
other family members had symptoms related with MeHg 
poisoning.
The present 
study
n = 1386
These are all of the oﬃcially registered inhabitants who lived
within about 15 km from the mouth of the Agano river
Measurement of hair mercury
All hair samples were collected before the restriction on
fish consumption from Agano river (July 1, 1965)∗
∗Niigata prefecture restricted the catching of
fish and shellfish from July 1, 1965
n = 1277
Persons who did not consult two
medical institutions. It is unknown if
they had signs or symptoms
suggestive of MeHg poisoning
n = 109
Subjects who voluntarily consulted
two medical institutions (Nuttari clinic
and Kido hospital)
n = 103
103 of 109 subjects were adults
Niigata surveys in June, 1965 n = 22701
(The first survey n = 2813)
(The second survey n = 19888)
(≧20 years old) in 1965
Figure 1: Sampling process of the study subjects.
Minamata, it was noted that sensory disturbance of the
bilateral distal extremities could be used as the gold standard
for the diagnosis of Minamata Disease (methyl mercury
poisoning-related neurological disorders) in the exposed
areas [16, 17].
Tactile sensation was estimated using a small paint brush
and pain sensation was tested using a roulette wheel. Visual
fields were examined by confrontation. Hearing impairment
was examined by tuning fork of 512Hz and a ticking watch.
Speech disturbances were examined by phonation of labial
and lingual sounds. Ataxia was determined by 3 tests; Adi-
adochokinesis, Finger-Nose, and Heel-Knee. Disequilibrium
was tested by 3 tests; Romberg test, Mann test, and standing
on one foot. Mann test is used to investigate the loss of
motor coordination. The procedure is as follows: the subject
stands with both legs on a straight line putting one toenail
behind the heel of the other foot and looks straight ahead
with eyes open and then closes both eyes. The subject repeats
the procedure reversing the positions of his feet. Mann test
is judged positive when the subject sways. For ataxia and
disequilibrium, each test was scored as positive (+), equivocal
(±), or negative (−). If one test in the group was positive that
category was classified as positive. If there were no positives
in the three tests and there was one and over (±) in the
category it was scored as equivocal. When all 3 tests were
negative, the category was classified as negative. When the
categories were classified as positive or equivocal, ataxia and
disequilibrium are scored positive in this study. The subjects
were all examined between June 1965 and July 1986. In
the present study, we examined neurological symptoms and
signs at the first consultation for the two medical institutions
(i.e., the closest findings to the hair mercury measurement of
June, 1965).
3. Analysis
First, we described the demographic characteristics of the
subjects by exposure category (0–≤20 µg/g, 20–50 µg/g,
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50–100 µg/g, and >100 µg/g). We then compared the preva-
lence proportions of neurological signs between the exposure
categories. We estimated the adjusted prevalence odds ratios
of exposure using a logistic regression model, employing
the lowest measured category as reference. We adjusted for
age and sex. We also conducted statistical tests for trend.
In a sensitivity analysis, we restricted the subjects whose
hair mercury concentration was measured by the Dithizone
method, which the previous publications from Niigata
adopted, and repeated the same analysis. All confidence
intervals were calculated at the 95% level. PASW software
version 18.0 was used for all analyses.
4. Results
The distribution of the 103 subjects among 1,386 persons
(who were measured mercury concentration) separated by
the exposure category is shown in Table 1. The persons who
had lower level of mercury concentration in hair tended
not to be consulted at the medical institutions. The char-
acteristics of the study subjects separated by the exposure
category are also shown in Table 2. The subjects in the highest
exposure category (>100 µg/g) tended to be younger in 1965,
men, and examined earlier after their signs appeared. About
seven-tenths of the samples (69.9%) were measured using
the Dithizone method, while about one-fourth (25.2%) by
Neutron Activation Analysis, and only 5 samples (4.9%) by
Atomic Absorption Spectroscopy.
Figure 2 and Table 3 show the frequency of neurological
signs related to MeHg poisoning separated by the hair
mercury content group. Distal sensory disturbance of the
bilateral extremities was most frequently detected (95.1%),
followed by disequilibrium (86.3%), hearing impairment
(75.5%), and ataxia (70.9%). Half of the subjects manifested
sensory disturbance of the perioral area (57.3%) and visual
constriction (44.2%). All of the subjects who had a perioral
sensory disturbance had a sensory disturbance of the bilateral
extremities. Even the subjects who had hair mercury levels
less than 50 µg/g had a variety of neurological signs related to
MeHg poisoning.
When we estimated the adjusted prevalence odds ratios
(Table 3), the associations between exposure and neurologi-
cal signs were not apparent because neurological sings were
detected even in the low exposure categories. Statistical dose-
response relationships were not apparent except perioral
sensory disturbance (P = 0.04).
Even when we restricted the subjects whose hair mercury
concentration was measured by the Dithizone method, the
28 subjects (Table 2) with hair mercury concentration less
than 50 µg/g had the neurological signs related to MeHg
poisoning.
5. Discussion
In the present study, we examined whether neurological signs
related to MeHg exposure were observed below hair mercury
concentration of 50 µg/g as well as the distributions of the
neurological signs in Niigata, Japan. We then found that
there were the 48 subjects with hair mercury concentration
less than 50 µg/g had the neurological signs related to MeHg
poisoning, that is, some of the subjects with the typical
neurological signs had hair mercury levels less than 50 µg/g.
Moreover, among the neurological signs, sensory disturbance
of the bilateral distal extremities, disequilibrium, hearing
impairment, and ataxia were observed more frequently.
Although the previous studies conducted in the same
exposed area (Niigata) suggested that the hair mercury
content from the initial patients ranged from 52 µg/g to
570 µg/g [11, 12, 14], the present study provided an addi-
tional finding that the subjects who had similar neurological
signs were detected even among the 48 subjects below hair
mercury concentration of 50 µg/g. Although we do not have
information about the neurological signs of 48 subjects at
survey time (in June 1965), they had a variety of neurological
signs related to MeHg poisoning when we examined. This
is probably because our study included the subjects who
manifested the signs later and who had less severe signs in
the low exposure level compared to the previous studies.
Given the sampling process of the present study (only
7.4% of the hair-mercury-measured subjects) (Figure 1 and
Table 1), theremay be a question about inferring that the per-
sons who have hair mercury concentration less than 50 µg/g
really manifest the typical neurological signs induced by
MeHg exposure. However, the notion that persons with the
low level of exposure manifest such neurological signs could
be supported by the following evidence: first, the prevalence
of such typical neurological signs among unexposed popu-
lation is rare (e.g., prevalence of sensory disturbance of the
bilateral distal extremities ranged from 0 to 1.1% [18–22]).
Second, as mentioned, it was noted that sensory disturbance
of the bilateral distal extremities could be used as the gold
standard for the diagnosis of Minamata Disease (methyl
mercury poisoning-related neurological disorders) in the
exposed areas [16, 17]. This evidence was supported by the
findings that sensory disturbance had the lowest threshold
[1]; milder cases only had sensory disturbance [1, 8]; sensory
disturbance was the most persistent neurologic sign [18];
the prevalence of sensory disturbance of the bilateral distal
extremities was low (as mentioned). Therefore, it could be
considered that the subjects in the present study who had
hair mercury concentration less than 50 µg/g manifested the
typical neurological signs because of MeHg exposure.
Moreover, even if we assumed that persons who did not
consult at the medical institutions did not have any typical
neurological signs, the prevalence of the neurological signs
would be still higher than that of general population For
example, 23, 23, 20, and 32 subjects had sensory disturbance
of the bilateral distal extremities in each exposure category
(0–<20, 20–50, 50–100, and >100 µg/g) (Table 3); thus, the
prevalence of the neurological sign was 2.5, 7.5, 22.0, and
52.5% in each category assuming that persons who did not
consult at the medical institutions did not have any typical
neurological signs (Table 1). The prevalence, in particular
in the categories of hair mercury levels less than 50 µg/g, is
still higher than that of general population mentioned above
(0 to 1.1% [18–22]). The present study therefore supports
that long-term exposure to MeHg at levels below the current
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Table 1: Distribution of the 103 subjects among 1,386 persons (whose hair mercury concentrations were measured) separated by the
exposure category.
0–≤20 µg/g 20–50µg/g 50–100µg/g >100 µg/g Total
(n = 926) (n = 308) (n = 91) (n = 61) (n = 1386)
Persons who did not consult two medical institutions 901 283 67 26 1277
Subjects in the present study 24 + 1∗(2.7%) 24 + 1(8.1%) 21 + 3(26.4%) 34 + 1(57.4%) 103 + 6(7.9%)
∗
Number after the plus sign shows the number of persons younger than 20 years old. Consequently, 103 subjects were included in the present study.
Source: Ministry of Health and Welfare.
Table 2: Characteristics of subjects by hair mercury content.
All 0–≤20 µg/g 20–50µg/g 50–100µg/g >100 µg/g
(n = 103) (n = 24) (n = 24) (n = 21) (n = 34)
Mean age in years (1965) ± SD 44.5± 12.9 45.3± 12.9 44.8± 12.4 49.5± 13.1 40.6± 12.4
Sex
Men 61 (59.2%) 11 (45.8%) 12 (50.0%) 12 (57.1%) 26 (76.5%)
Women 42 (40.8%) 13 (54.2%) 12 (50.0%) 9 (42.9%) 8 (23.5%)
Date symptoms began 1964–1973 1964–1973 1964–1970 1964–1972 1964–1971
Mean age in years (±SD) that symptoms began 45.5± 12.8 46.0± 12.8 46.5± 13.5 51.4± 13.0 40.4± 10.7
Mean age in years of assessment of neurologic signs± SD 50.7± 13.0 53.9± 12.4 52.4± 12.5 56.3± 11.7 43.6± 11.7
Mean hair mercury content ± SD (µg/g) 107.6± 123.1 13.2± 4.5 32.6± 8.5 72.6± 13.9 248.8± 121.4
Hair mercury content (µg/g) (min-max) 4.2–570.0 4.2–19.5 20.5–46.6 56.0–100.0 104.0–570.0
Analysis method of hair mercury (1965)
Dithizone 72 (69.9%) 10 (41.7%) 18 (75.0%) 13 (61.9%) 31 (91.2%)
Neutron activation 26 (25.2%) 13 (54.2%) 6 (25.0%) 5 (23.8%) 2 (5.9%)
Atomic absorption 5 (4.9%) 1 (4.1%) 0 (0%) 3 (14.3%) 1 (2.9%)
SD: standard deviation.
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Table 3: Adjusted PORs∗ and their 95% C.I.s between mercury content and neurological signs.
0–≤20 µg/g 20–50µg/g 50–100µg/g >100 µg/g
P value for trend
(n = 24) (n = 24) (n = 21) (n = 34)
Dis.dom.bil. S.D. n (%) 23 (95.8) 23 (95.8) 20 (95.2) 32 (94.1)
PORs and 95% CIs 1 1.0 (0.1, 18.1) 0.6 (0, 11.7) 0.7 (0, 10.4) 0.74
Perioral S.D. n (%) 10 (41.7) 12 (50) 16 (76.2) 21 (61.8)
PORs and 95% CIs 1 1.4 (0.5, 4.5) 4.3 (1.2, 16) 2.7 (0.9, 8.3) 0.04
Whole body S.D. n (%) 0 (0) 2 (8.3) 0 (0) 1 (3)
PORs and 95% CIs 1 NE NE NE 0.98
Ataxia n (%) 17 (70.8) 17 (70.8) 18 (85.7) 27 (79.4)
PORs and 95% CIs 1 1.0 (0.3, 3.8) 2.2 (0.5, 10.5) 2.3 (0.6, 8.9) 0.14
Visual constriction n (%) 11 (45.8) 11 (45.8) 7 (41.2) 13 (43.3)
PORs and 95% CIs 1 1.0 (0.3, 3.5) 0.5 (0.1, 2) 1.1 (0.3, 3.6) 0.89
Hearing impairment n (%) 16 (72.7) 19 (86.4) 15 (78.9) 20 (64.5)
PORs and 95% CIs 1 2.6 (0.5, 13.2) 1.1 (0.2, 5.1) 0.6 (0.1, 2.2) 0.25
Speech disturbance n (%) 3 (13) 4 (16.7) 4 (23.5) 8 (25)
PORs and 95% CIs 1 1.2 (0.2, 6.9) 1.4 (0.2, 8.4) 1.8 (0.4, 8.8) 0.45
Disequilibrium n (%) 20 (83.3) 21 (87.5) 16 (80) 31 (91.2)
PORs and 95% CIs 1 1.4 (0.3, 7.1) 0.7 (0.1, 3.4) 1.9 (0.3, 10) 0.66
∗
Prevalence odds ratios were estimated using 0–20 ppm as a reference and were adjusted for age and sex.
Abbreviations: C.I.: confidence interval; Dis.dom.bil.: distal dominant bilateral; NE: not estimatable; POR: prevalence odds ratio.
WHO limits could cause neurologic signs, in particular,
sensory disturbance, which is consistent with the view of
the National Research Council (US) [23] and the previous
studies conducted in Brazil [24] and Minamata [10].
The finding that the dose-response relationship was
observed for perioral sensory disturbance (Table 3) was con-
sistent with the previous study inMinamata [10]. The reason
why the dose-response relationships were not observed for
other neurological sings could be explained by the sampling
process. It is likely that the subjects who did not have the
neurological signs in the lower level of the mercury exposure
did not consult the doctors, probably diminishing the dose-
response relationships.
There is a concern that the hair mercury level measured
in June 1965 may not reflect the peak exposure of the
subjects. However, the hair mercury concentration of the
subjects was measured at the relatively early phase of the
outbreak. In addition, all of the hair samples were collected
before the restriction of fishing; thus, the subjects were
considered to be consuming the contaminated fish (at that
time) and their hair mercury values were thought to be close
to the peak exposure value. Thus, such a concern would not
invalidate our result.
In the present study, a sensory disturbance of the bilateral
distal extremities was most frequently detected (95.1%),
followed by disequilibrium (86.3%), hearing impairment
(75.5%), and ataxia (70.9%). Half of the subjects had sensory
disturbance of the perioral area (57.3%) and visual constric-
tion (44.2%). This tendency that the sensory disturbance
was the most prevalent sign is consistent with the previous
studies in Niigata [25] and Minamata [4] which examined
the prevalence of the neurological signs among the exposed
subjects.
The possible limitation of the present study is that there
were three diﬀerent methods for hair mercury measurement.
Hoshino et al. [26] measured total mercury content in hair
samples from 3 Niigata Minamata disease patients and their
17 family members by using two techniques (the Neutron
Activation Analysis and the Dithizone Method) and showed
that the values from the twomethods were similar. Moreover,
Tsubaki [14] measured same samples by using the Dithizone
Method and Atomic Absorption Analysis, then they showed
that the values were the same between the two methods.
Therefore, the diﬀerent methods for hair mercury mea-
surement would not explain the present results. Moreover,
restricting the subjects whose hair mercury concentration
was measured by the Dithizone Method did not alter the
results in the sensitivity analysis.
As mentioned, another limitation is the sampling process
of the present study. We could not obtain the information
about health status of the 1277 persons who did not consult
the doctors. This may aﬀect the dose-response relationships
and the obtained prevalence of the neurological signs in
each exposure category. However, this limitation does not
aﬀect the present finding that there were subjects with the
neurological signs related toMeHg poisoning in the exposure
category of hair mercury levels less than 50 µg/g.
6. Conclusions
The present study, conducted in Niigata Japan, showed
that the subjects with the neurological signs related to
MeHg poisoning had hair mercury levels less than 50 µg/g
and suggested the possibility that long-term exposure to
MeHg at levels below the current WHO limits could cause
neurologic signs, in particular, sensory disturbance. Among
the neurological signs, sensory disturbances of bilateral
extremities were the most common. These findings may
provide additional evidence for MeHg toxicity from contam-
inated seafood intake.
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